Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
26
RGNX Quote, Financials, Valuation and Earnings
Last price:
$8.68
Seasonality move
:
7.97%
Day range:
$8.51 - $8.95
52-week range:
$5.04 - $15.36
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.82x
P/B ratio:
1.59x
Volume:
512.1K
Avg. volume:
871.6K
1-year change:
-34.56%
Market cap:
$435.9M
Revenue:
$83.3M
EPS (TTM):
-$3.11
Earnings Data
Next earnings date for RGNX
Aug 01
2025
Most recent earnings per share
$0.12
Missed by $0.37
(May 12/2025)
Consensus Estimate
$0.49
(May 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RGNX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $110M | -- | -- | $1.08 | -- |
| 08/01/2025 | Q2 | $40.9M | -- | -- | -$1.05 | -- |
| 05/12/2025 | Q1 | $105.4M | $89M | $0.12 | $0.49 | -$0.37 |
| 03/13/2025 | Q4 | $23.7M | $21.2M | -$1.01 | -$1.08 | $0.07 |
| 11/06/2024 | Q3 | $24.4M | $24.2M | -$1.17 | -$1.10 | -$0.07 |
| 08/01/2024 | Q2 | $23M | $22.3M | -$1.05 | -$1.31 | $0.26 |
| 05/08/2024 | Q1 | $23.5M | $15.6M | -$1.38 | -$1.26 | -$0.12 |
| 02/27/2024 | Q4 | $34M | $22.2M | -$1.42 | -$1.28 | -$0.14 |
| 11/08/2023 | Q3 | -- | -- | -$1.41 | -$1.52 | $0.11 |
| 08/02/2023 | Q2 | -- | -- | -$1.66 | -$1.21 | -$0.45 |
| 05/03/2023 | Q1 | -- | -- | -$1.53 | -$1.41 | -$0.12 |
| 02/28/2023 | Q4 | -- | -- | -$1.38 | -$1.17 | -$0.21 |
| 11/03/2022 | Q3 | -- | -- | -$1.75 | -$1.46 | -$0.29 |
| 08/03/2022 | Q2 | -- | -- | -$1.58 | -$1.54 | -$0.04 |
| 05/04/2022 | Q1 | -- | -- | -$1.79 | -$1.29 | -$0.51 |
| 03/01/2022 | Q4 | -- | -- | $6.67 | $4.31 | $2.36 |
| 11/02/2021 | Q3 | -- | -- | -$1.37 | -$1.12 | -$0.25 |
| 08/09/2021 | Q2 | -- | -- | -$1.36 | -$1.16 | -$0.21 |
| 05/05/2021 | Q1 | -- | -- | -$1.20 | -$1.30 | $0.10 |
| 03/01/2021 | Q4 | -- | -- | -$1.24 | -$1.16 | -$0.08 |
| 11/04/2020 | Q3 | -- | -- | $0.23 | -$1.01 | $1.24 |
| 08/06/2020 | Q2 | -- | -- | -$0.91 | -$0.93 | $0.02 |
| 05/07/2020 | Q1 | -- | -- | -$1.08 | -$1.01 | -$0.08 |
| 02/26/2020 | Q4 | -- | -- | -$0.72 | -$0.95 | $0.23 |
| 11/05/2019 | Q3 | -- | -- | -$0.94 | -$0.24 | -$0.70 |
| 08/07/2019 | Q2 | -- | -- | -$0.83 | -$0.77 | -$0.07 |
| 05/07/2019 | Q1 | -- | -- | -$0.89 | -$0.89 | $0.00 |
| 02/27/2019 | Q4 | -- | -- | $0.11 | -$0.33 | $0.44 |
| 11/07/2018 | Q3 | -- | -- | -$0.56 | -$0.81 | $0.25 |
| 08/08/2018 | Q2 | -- | -- | $0.30 | $0.56 | -$0.26 |
| 05/08/2018 | Q1 | -- | -- | $3.04 | $1.07 | $1.97 |
| 03/06/2018 | Q4 | -- | -- | -$0.51 | -$0.83 | $0.32 |
| 11/08/2017 | Q3 | -- | -- | -$0.67 | -$0.73 | $0.06 |
| 08/08/2017 | Q2 | -- | -- | -$0.47 | -$0.80 | $0.33 |
| 03/31/2017 | Q1 | -- | -- | -$0.82 | -$0.77 | -$0.05 |
Regenxbio Earnings Questions
-
How Much did Regenxbio Generate in Revenue Last Quarter?
Regenxbio reported $89M worth of top line sales in its most recent quarter.
-
Did Regenxbio Beat Earnings Last Quarter?
Regenxbio announced earnings per share of $0.12 which represents a miss of analyst forecast a $0.49 per share.
-
Is Regenxbio Profitable?
Regenxbio reported $85.6M that represents $1.66 per share over the last quarter.
-
What is the Analyst Consensus for Regenxbio EPS Next Year?
Regenxbio's earnings are forecast to decrease from -$4.59 per share to -$4.76 per share next year representing a decrease of -78.6%.
-
When is Regenxbio's Earnings Date?
Regenxbio's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
